Clinical Trial Update: Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

View source ↗

Summary

This clinical trial update notes a Novo Nordisk haemophilia study in the Asia-Pacific region that is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia | Status: ENROLLING_BY_INVITATION